Synaptic Therapy Alzheimer's Research Trial (START): A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease over 18 Months

15410COG0203OpenSynaptic Therapy Alzheimer's Research Trial (START): A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease over 18 MonthsNCT05531656IndustrialAdultTreatmentOtherTurner, RaymondGeorgetown University Medical Center : Angelica Forero; Lombardi Comprehensive Cancer Center : Angelica Forero13104Angelica ForeroAngelica Foreroaf1193@georgetown.edu2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>